The Drug Development program works to develop and deliver lifesaving medicines to women, children, and communities around the globe.
Despite the tremendous number of people affected by infectious and neglected tropical diseases, these conditions remain on the margins of international attention, priority, and funding. Most often, these health problems are closely linked with poverty and poor access to clean water, safe sanitation, and health care services.
There is an urgent need to expand the available tools that can save lives, as well as alleviate the burden of related conditions, such as malnutrition and stunting. With deep expertise in drug research and development, we work to bridge the gap by collaborating across sectors to advance affordable and effective treatments. Through our work on drug development and introduction, we help to ensure that people around the world, especially young children, have access to life-saving medicines that can end illness and deaths due to common childhood illnesses, including diarrhea and pneumonia, and neglected tropical diseases.
In collaboration with country, industry, and public- and private-sector stakeholders, we identify and advance solutions to confront these threats so more children are protected and have the best chance to thrive.
Our strategy is to prioritize illnesses and conditions that disproportionately affect the world’s most vulnerable populations; identify and develop promising drug candidates by focusing leading science and public health expertise on those illnesses; and work closely with partners in endemic settings to ensure that products are available, accessible, and affordable at the national, community, and individual level.
We advance our efforts by: